Related Experiment Videos
Rattus norvegicus: not a model for Aeromonas-associated gastroenteritis in man
1Discipline of Pathology, University of Tasmania, Hobart, Australia.
FEMS Immunology and Medical Microbiology
|July 13, 2000
Summary
This study investigated the clindamycin-treated rat model for Aeromonas-associated diarrhea. Researchers found it unsuitable for studying Aeromonas enteropathogenicity due to poor bacterial colonization and lack of intestinal damage.
Area of Science:
- Microbiology
- Infectious Diseases
- Animal Models
Background:
- Investigating Aeromonas pathogenic mechanisms is hindered by the absence of a suitable animal model for Aeromonas-associated diarrhea.
- A previous report suggested clindamycin-pretreated rats could serve as a model for Aeromonas enteritis.
Purpose of the Study:
- To investigate the validity of the clindamycin-treated rat model for studying Aeromonas enteropathogenicity.
- To determine if Aeromonas species can colonize and cause histological damage in clindamycin-pretreated rats.
Main Methods:
- Six Aeromonas strains were inoculated intragastrically into clindamycin-pretreated rats.
- Bacterial recovery from stools and intestinal histology were assessed post-inoculation.
- Comparison was made with Pseudomonas aeruginosa colonization in the same model.
Main Results:
- Aeromonas strains showed limited colonization (≤2 days) and did not cause significant histological damage.
- Pseudomonas aeruginosa, however, demonstrated long-term colonization (>12 days) and histological damage.
- Bacterial destruction in vivo appeared to be mediated by immune mechanisms, not bacterial sensitivity.
Conclusions:
- The clindamycin-treated rat model is not suitable for investigating the enteropathogenicity of Aeromonas species.
- The model's inability to support Aeromonas colonization and induce disease contrasts with its efficacy for Pseudomonas aeruginosa.
- Further research is needed to understand the discrepancy with previous findings and explore alternative models.